MALARONE Pediatric 62.5 mg / 25 mg Oral Tablet
RxNorm 864685
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 864685 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: MALARONE Pediatric 62.5 mg / 25 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
Atovaquone 62.5 mg / proguanil hydrochloride 25 mg Oral Tablet [Malarone]
(Atom ID: 12360739)
SYPrescribable
Synonym (SY):
Malarone 62.5/25 (atovaquone / proguanil HCl) Oral Tablet
(Atom ID: 3264137)
SYPrescribable
Synonym (SY):
Malarone 62.5/25 Oral Tablet
(Atom ID: 3264224)
PSNPrescribable
Prescribable Name (PSN):
MALARONE Pediatric 62.5 mg / 25 mg Oral Tablet
(Atom ID: 6367087)
Patient Education
Atovaquone and Proguanil
The combination of atovaquone and proguanil is used to treat a certain kind of malaria infection (a serious infection that is spread by mosquitoes in certain parts of the world and can cause death) and to prevent a certain kind of malaria infection in travelers who visit areas where malaria is common. Atovaquone and proguanil is in a class of medications called antimalarials. It works by killing the organisms that cause malaria.
[Learn More]
* Please review the disclaimer below.